Advertisement


Related Videos

Opening Session Panel Discussion

Opportunities to Optimize Cancer Policies Panel Discussion

Varsha Gandhi, PhD, on Ibrutinib

Mark J. Ratain, MD: The Justification for a Randomized Trial of Low-Dose Ibrutinib

The Interventional Pharmacoeconomic Toolbox Panel Discussion

Advertisement

Advertisement



Oct
04
Today In Oncology
Study Focuses on Molecular Details of Precancerous Clonal Outgrowth in Blood Cells
Researchers Identify Potential Biomarker to Distinguish Group 3 and Group 4 Medulloblastomas
Novel Gamma Secretase Inhibitor Halts Progression of Desmoid Tumors
Fertility Preservation Procedures at Breast Cancer Diagnosis Risk of Relapse and Disease-Specific Mortality
T-DXd for Patients With HER2-Low Metastatic Breast Cancer Patient-Reported Outcomes
View More 
Advertisement
© 2022 HSP News Service, L.L.C.
Designed by Harborside